Article Information
History
- July 24, 2016.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Xi-Ping Huang1,2,
- Tao Che1,
- Thomas J Mangano1,2,
- Valerie Le Rouzic3,
- Ying-Xian Pan,
- Susruta Majumdar3,
- Michael Cameron4,
- Michael Bauman5,
- Gavril W. Pasternak3 and
- Bryan L Roth1,2,6
- 1Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, NC 27514
- 2NIMH Psychoactive Drug Screening Program, Chapel Hill, NC 27514
- 3Department of Neurology and Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065
- 4Department of Molecular Therapeutics, The Scripps Research Institute, Jupiter, FL 33458
- 5Designer Drug Research Unit, National Institute on Drug Abuse Baltimore, MD 21224
- ↵6Correspondence to: Bryan L. Roth MD, PhD 4072 Genetic Medicine Building, Department of Pharmacology, UNC School of Medicine, Chapel Hill, NC 27514. email: bryan_roth{at}med.unc.edu 919-966-7535 (Office) 919-843-5788 (Fax)